Incidence early ovarian cancer early detection of cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast Ovary Epithelial Cells Prostate Neoplastic Cells, Circulating

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases58

Ovarian Neoplasms Uterine Cervical Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Prostatic Neoplasms Cystadenocarcinoma, Serous Neoplasms Lung Neoplasms Neoplasm Invasiveness Carcinoma Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Genetic Predisposition to Disease Pancreatic Neoplasms Disease Progression Colorectal Neoplasms Neoplasm Recurrence, Local Carcinoma, Squamous Cell Adenocarcinoma, Clear Cell Adenocarcinoma, Mucinous Endometrial Neoplasms Peritoneal Neoplasms Adenocarcinoma Carcinoma, Endometrioid Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Cell Transformation, Neoplastic Ascites Precancerous Conditions Esophageal Neoplasms Mouth Neoplasms Liver Neoplasms Rectal Neoplasms Skin Neoplasms Genital Neoplasms, Female Neoplasms, Second Primary Neovascularization, Pathologic Cystadenocarcinoma Neoplastic Syndromes, Hereditary Head and Neck Neoplasms Fallopian Tube Neoplasms Neoplasms, Radiation-Induced Melanoma Disease Models, Animal Neoplasms, Multiple Primary Bone Neoplasms Gastrointestinal Neoplasms Pharyngeal Neoplasms Carcinoma, Small Cell Neoplasms, Hormone-Dependent Carcinoma in Situ Neoplasms, Cystic, Mucinous, and Serous Adenoma Thyroid Neoplasms Hereditary Breast and Ovarian Cancer Syndrome Neoplastic Cells, Circulating Breast Neoplasms, Male

Chemicals and Drugs48

CA-125 Antigen Tumor Markers, Biological Antineoplastic Agents Neoplasm Proteins Cisplatin Paclitaxel RNA, Messenger Cancer Vaccines BRCA2 Protein DNA, Neoplasm BRCA1 Protein Antineoplastic Agents, Phytogenic Antigens, Neoplasm Prostate-Specific Antigen RNA, Small Interfering Receptor, erbB-2 Epididymal Secretory Proteins Receptors, Estrogen Tumor Suppressor Protein p53 Antibodies, Monoclonal Carboplatin MicroRNAs DNA Primers Receptors, Progesterone Tumor Suppressor Proteins Tamoxifen RNA, Neoplasm Fluorouracil Receptor, Epidermal Growth Factor Biological Markers Antigens, Tumor-Associated, Carbohydrate Antineoplastic Agents, Hormonal Anticarcinogenic Agents DNA-Binding Proteins Taxoids Transcription Factors Proto-Oncogene Proteins Platinum Nuclear Proteins Carcinogens Deoxycytidine Carcinoembryonic Antigen Antibodies, Monoclonal, Humanized Organoplatinum Compounds Proto-Oncogene Proteins c-akt Antimetabolites, Antineoplastic Antibiotics, Antineoplastic Estrogens

Analytical, Diagnostic and Therapeutic Techniques and Equipment77

Early Detection of Cancer Mammography Mass Screening Vaginal Smears Incidence Early Diagnosis Sensitivity and Specificity Prognosis Risk Factors Neoplasm Staging Retrospective Studies Prospective Studies Survival Analysis Polymerase Chain Reaction Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Survival Rate Antineoplastic Combined Chemotherapy Protocols Reproducibility of Results Risk Registries Gene Expression Profiling Risk Assessment Xenograft Model Antitumor Assays Predictive Value of Tests Disease-Free Survival Blotting, Western Treatment Outcome Odds Ratio Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Combined Modality Therapy Cohort Studies Immunohistochemistry Multivariate Analysis Genetic Testing Questionnaires Kaplan-Meier Estimate Enzyme-Linked Immunosorbent Assay Transplantation, Heterologous ROC Curve Logistic Models SEER Program Case-Control Studies Limit of Detection Immunoenzyme Techniques Chemotherapy, Adjuvant Tumor Burden Drug Screening Assays, Antitumor Clinical Trials as Topic Tissue Array Analysis Neoplasm Grading Confidence Intervals Biopsy DNA Mutational Analysis Prevalence Flow Cytometry Models, Biological Transfection Drug Administration Schedule Molecular Targeted Therapy False Positive Reactions Disease Models, Animal Breast Self-Examination Tomography, X-Ray Computed Real-Time Polymerase Chain Reaction Gene Knockdown Techniques Immunoassay Radiotherapy Cluster Analysis Colonoscopy Regression Analysis Pilot Projects Feasibility Studies Chi-Square Distribution Positron-Emission Tomography Evaluation Studies as Topic

Psychiatry and Psychology2

Smoking Breast Self-Examination

Phenomena and Processes46

Sensitivity and Specificity Gene Expression Regulation, Neoplastic Genes, BRCA1 Drug Resistance, Neoplasm Genetic Predisposition to Disease Risk Mutation Genes, BRCA2 Time Factors DNA Methylation Odds Ratio Germ-Line Mutation Genotype Cell Proliferation Apoptosis Cell Survival Base Sequence Dose-Response Relationship, Drug Cell Movement Down-Regulation Promoter Regions, Genetic Cell Division Genes, Tumor Suppressor Polymorphism, Genetic Up-Regulation Cell Growth Processes Algorithms Cell Cycle Signal Transduction Transfection Gene Silencing RNA Interference Genes, Neoplasm Gene Expression Phenotype Heterozygote Alleles Genes, p53 Diet Postmenopause Drug Synergism Gene Amplification Epigenesis, Genetic Chi-Square Distribution Pregnancy Phosphorylation

Disciplines and Occupations4

Immunohistochemistry Medical Oncology Proteomics Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena3

National Cancer Institute (U.S.)Age Distribution Quality of Life

Humanities1

Quality of Life

Information Science9

Incidence Survival Rate Registries Questionnaires Base Sequence SEER Program Molecular Sequence Data Algorithms Prevalence

Named Groups4

Medically Uninsured Survivors Infant, Newborn European Continental Ancestry Group

Health Care41

Mass Screening Incidence Sensitivity and Specificity Risk Factors Retrospective Studies Prospective Studies Survival Analysis Follow-Up Studies Survival Rate Reproducibility of Results Risk Registries Risk Assessment Predictive Value of Tests Disease-Free Survival Treatment Outcome Odds Ratio Age Factors Cohort Studies Multivariate Analysis National Cancer Institute (U.S.)Genetic Testing Questionnaires Kaplan-Meier Estimate ROC Curve Logistic Models SEER Program Case-Control Studies Limit of Detection Age Distribution Clinical Trials as Topic Confidence Intervals Prevalence American Cancer Society Cluster Analysis Genetic Counseling Regression Analysis Pilot Projects Feasibility Studies Chi-Square Distribution Evaluation Studies as Topic

Geographicals5

United States Japan China Sweden Europe

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Early Detection of Cancer Mammography Uterine Cervical Neoplasms Mass Screening Medically Uninsured Breast Neoplasms Vaginal Smears United States Incidence Neoplasms, Glandular and Epithelial Early Diagnosis Sensitivity and Specificity CA-125 Antigen Tumor Markers, Biological Prostatic Neoplasms Cell Line, Tumor Gene Expression Regulation, Neoplastic Cystadenocarcinoma, Serous Neoplasms Lung Neoplasms Prognosis Genes, BRCA1 Neoplasm Invasiveness Carcinoma Risk Factors Mice, Nude Neoplasm Staging Retrospective Studies Antineoplastic Agents Prospective Studies Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Proteins Drug Resistance, Neoplasm Survival Analysis Polymerase Chain Reaction Follow-Up Studies Genetic Predisposition to Disease Reverse Transcriptase Polymerase Chain Reaction Survival Rate Pancreatic Neoplasms Disease Progression Antineoplastic Combined Chemotherapy Protocols Reproducibility of Results Cisplatin Risk Registries Mutation Gene Expression Profiling Genes, BRCA2 Paclitaxel Risk Assessment Time Factors Xenograft Model Antitumor Assays Colorectal Neoplasms Neoplasm Recurrence, Local RNA, Messenger Cancer Vaccines Carcinoma, Squamous Cell BRCA2 Protein Predictive Value of Tests DNA, Neoplasm DNA Methylation BRCA1 Protein Adenocarcinoma, Clear Cell Disease-Free Survival Adenocarcinoma, Mucinous Blotting, Western Endometrial Neoplasms Treatment Outcome Peritoneal Neoplasms Odds Ratio Adenocarcinoma Carcinoma, Endometrioid Urinary Bladder Neoplasms Age Factors Neoplasm Transplantation Germ-Line Mutation Tumor Cells, Cultured Oligonucleotide Array Sequence Analysis Genotype Antineoplastic Agents, Phytogenic Cell Proliferation Combined Modality Therapy Antigens, Neoplasm Prostate-Specific Antigen Carcinoma, Non-Small-Cell Lung Cohort Studies Immunohistochemistry Multivariate Analysis National Cancer Institute (U.S.)Genetic Testing Apoptosis RNA, Small Interfering Cell Transformation, Neoplastic Receptor, erbB-2 Ascites Epididymal Secretory Proteins

No FAQ available that match "incidence early ovarian cancer early detection of cancer"